RSS Feed
Search Ask-Cato.com
Tags
adverse events biologics biomarkers biosimilar biotech cancer Cato BioVentures Cato Research CDER clinical investigator clinical research clinical trials CMC conference CROs DIA drug development eCTD efficacy FDA funding GlobalSubmit guidance Health Canada IND in vitro diagnostics manufacturing marketing application medical devices NDA NIH nonclinical research oncology Phase 1 Phase 2 PMA postmarketing protocol safety statistical analysis toxicology transparency vaccines venture capital webinarCategories
- Clinical Trials (55)
- Conferences and Meetings (35)
- eCTD (26)
- FDA (78)
- Guest Posts (5)
- Health Canada (6)
- Industry News (62)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (39)
- Social Media (6)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (10)
- Webinars (24)
Category Archives: Conferences and Meetings
Conference Recap – BayBio 2011
The BayBio Annual Conference 2011 was held on 20-21 April 2011 in Burlingame, CA. The event was attended by more than 1,000 San Francisco Bay Area biotech and life sciences professionals from over 400 companies. This year’s conference focused on … Continue reading
Posted in Conferences and Meetings, Venture Capital
Tagged BayBio, biotech, Cato BioVentures, clinical development, CROs, drug candidate, drug development, funding, marketing, nonprofits, Northern California, Orphan Drug Designations, Phase 1, Phase 2, regulatory strategy, risk, safety, venture capital
Comments Off
Conference Recap – 2011 Society of Toxicology Annual Meeting
The Society of Toxicology’s (SOT) 50th Anniversary Annual Meeting was held on 05-10 March 2011 in Washington, DC. Several members of Cato Research’s Nonclinical Sciences Development group were amongst the more than 7,000 toxicologists from 50 countries in attendance this … Continue reading
Posted in Conferences and Meetings
Tagged FDA, Margaret Hamburg, NIH, nonclinical research, preclinical, safety, toxicology
Comments Off
Recap of the NCCN 16th Annual Conference
The 16th Annual National Comprehensive Cancer Network Conference (NCCN): Clinical Practice Guidelines and Quality Cancer Care, was held on 09-13 March 2011 in Hollywood, FL. The conference hosted almost 2,000 registrants including oncologists, nurses, pharmacist, and other health care professionals. … Continue reading
Posted in Conferences and Meetings
Tagged cancer, clinical trials, conference, FDA, oncology
Comments Off
Recap of the 20th CED Biotech/Life Sciences Conference
The 20th Annual Council for Entrepreneurial Development (CED) Biotech/Life Science Conference was held on 21-22 February 2011 in Raleigh, North Carolina. Continue reading
Posted in Conferences and Meetings, Industry News, Venture Capital
Tagged biotech, capi, Cato BioVentures, Cato Research, clinical research, conference, development plan, drug development, funding, healthcare reform, Phase 2, Phase 3, venture capital
Comments Off
Early Oncology Partnering Forum
From 21-22 February 2011, Cato Research will be attending the Early Oncology Partnering Forum held in San Francisco, CA. This conference facilitates and encourages discussion and collaborations between companies that are developing innovative products with more established companies as partners. … Continue reading
Posted in Conferences and Meetings
Tagged biotech, Cancer Advances, Cato Research, clinical trials, Colorectal cancer, conference, early, gastric cancer, immune system, pancreatic cancer, San Francisco
Comments Off
